Drug Information

Drug General Information
Drug ID
D08QHX
Former ID
DCL001223
Drug Name
PRX00933
Indication Obesity; Diabetes [ICD9: 250, 278; ICD10:E08-E13, E66] Phase 2 [551552]
Company
Proximagen Group plc
Target and Pathway
Target(s) 5-hydroxytryptamine 2C receptor Target Info Agonist [551552]
KEGG Pathway Calcium signaling pathway
Neuroactive ligand-receptor interaction
Gap junction
Serotonergic synapse
Inflammatory mediator regulation of TRP channels
PANTHER Pathway 5HT2 type receptor mediated signaling pathway
Reactome Serotonin receptors
G alpha (q) signalling events
WikiPathways Serotonin Receptor 2 and ELK-SRF/GATA4 signaling
Monoamine GPCRs
GPCRs, Class A Rhodopsin-like
Gastrin-CREB signalling pathway via PKC and MAPK
GPCR ligand binding
GPCR downstream signaling
References
Ref 5515522011 Pipeline of Proximagen Group plc.
Ref 5515522011 Pipeline of Proximagen Group plc.